JAGUAR HEALTH INC (JAGX)
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
$0.41-18.38%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
QuarterlyIQ Insights · JAGX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||
| Revenues | 27.8 | 11.5 | 11.7 | 9.8 | 12.0 | 4.3 | 9.4 | 5.8 | 4.4 | 4.4 | 0.1 | 0.3 |
| Total Revenues | 27.8 | 11.5 | 11.7 | 9.8 | 12.0 | 4.3 | 9.4 | 5.8 | 4.4 | 4.4 | 0.1 | 0.3 |
| Cost of Revenues | — | 0.1 | 2.0 | 2.0 | 2.0 | 2.3 | 3.3 | 3.8 | 2.8 | 0.9 | 0.1 | 0.1 |
| Operating Expenses & Income | ||||||||||||
| R&D Expenses | 25.2 | 25.0 | 16.5 | 18.6 | 17.6 | 15.1 | 6.4 | 5.8 | 5.2 | 4.3 | 7.2 | 6.5 |
| Operating Income | (25.9) | (45.9) | (30.8) | (34.3) | (34.4) | (40.7) | (26.6) | (28.9) | (30.8) | (34.2) | (13.6) | (12.4) |
| Earnings from Continuing Operations | ||||||||||||
| Interest Expense | 1.0 | 0.1 | 0.2 | 6.4 | 12.7 | 8.4 | 2.8 | 5.7 | 2.6 | 1.2 | 1.0 | 3.3 |
| Asset Writedown | — | — | — | — | 0.0 | 0.0 | 0.0 | — | — | — | — | — |
| EBT, Incl. Unusual Items | (36.9) | (54.0) | (39.3) | (41.9) | (48.4) | (52.6) | (33.8) | (38.5) | (32.1) | (35.1) | — | — |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | (13.2) | (13.2) | — | — |
| Net Income | ||||||||||||
| Minority Interest | (0.5) | (0.6) | (0.8) | (0.6) | (0.9) | (0.0) | — | — | — | — | — | — |
| Net Income | 16.7 | (53.6) | (38.5) | (0.0) | (0.0) | (0.1) | (33.8) | (38.5) | (32.1) | (22.0) | (14.7) | (16.3) |
| Per Share | ||||||||||||
| Basic EPS | 20.69 | (22.97) | (130.69) | — | (36.18) | (88.22) | (3.00) | — | — | — | — | — |
| Diluted EPS | 20.69 | (22.97) | (130.69) | — | (36.18) | (88.22) | (3.00) | — | — | — | — | — |
| Revenue per Share | 34.38 | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 0.8 | 2.3 | 0.3 | 0.0 | 1.3 | 0.6 | 12.9 | — | — | — | — | — |
| Diluted Weighted Avg Shares | 0.8 | 2.3 | 0.3 | 0.0 | 1.3 | 0.6 | 12.9 | — | — | — | — | — |
| Supplemental | ||||||||||||
| EBITDA | — | (44.0) | (28.9) | (32.3) | (32.4) | (39.0) | (24.9) | (27.2) | (29.5) | (33.7) | (13.5) | (12.4) |
| EBIT | (25.9) | (45.9) | (30.8) | (34.3) | (34.4) | (40.7) | (26.6) | (28.9) | (30.8) | (34.2) | (13.6) | (12.4) |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | -0.0% | 41.0% | 37.5% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.